Rapid Approvals of New Therapies to Augment the Major Depressive Disorder (MDD) Treatment Market Growth

 

Major depressive disorder, also called clinical depression, is an extremely serious psychiatric disorder characterized by at least 2 weeks of persistent, severe, and unpredictable low mood. Loss of interest in normally pleasurable activities, lowered self-esteem, low energy, aches and pains without a definite cause, and feelings of worthlessness and guilt are typical symptoms. 

 

Diagnosis usually depends on the medical history of the patient and is made according to the Diagnostic and Statistical Manual for Mental Disorders IV-TR, which lists disorders in three categories based on the extent of the symptoms, the signs or symptoms, the time period they last for, the reaction of the patient to normal situations, and the patient's reaction to stress.

Market Dynamics:

Rapid approvals of new therapies from regulatory bodies, such as the United States Food and Drug Administration and the European Commission, are expected to augment the growth of the major depressive disorder (MDD) treatment market. For instance, in February 2021, The Janssen Pharmaceutical Companies of Johnson & Johnson announced that the European Commission has authorized the use of SPRAVATO (esketamine nasal spray), co-administered with oral antidepressant therapy in adults with a moderate to severe episode of major depressive disorder (MDD), as acute short term treatment, for the rapid reduction of depressive symptoms.

Moreover, increasing prevalence of MDD, especially in North America, is expected to propel the growth of the major depressive disorder (MDD) treatment market. MDD is one of the most common mental health disorders in the United States. For instance, according to the Anxiety and Depression Association of America (ADAA), MDD affects more than 16.1 million American adults, or about 6.7% of the U.S. population age 18 and older.

Increasing awareness about various depression episodes and the growing geriatric population worldwide is expected to offer lucrative growth opportunities for players in the market.

Competitive Analysis:

Major players operating in the major depressive disorder (MDD) treatment market are Eli Lilly and Company, Sanofi S.A., GlaxoSmithKline, Merck & Co., AstraZeneca Plc., Pfizer, Johnson & Johnson, Lundbeck, Alkermes, Allergan, and Takeda Pharmaceutical Company Limited.

In February 2021, Otsuka and Click Therapeutics announced the initiation of the Mirai study, a landmark fully remote clinical trial to investigate the effectiveness of digital therapeutics in reducing depressive symptoms in adults diagnosed with major depressive disorder (MDD).

In February 2021, MYND Life Sciences Inc. signed a Collaborative Research Agreement with the University of British Columbia focusing on Major Depressive Disorder (MDD), often referred to as depression.

Animation Design Software Market is expanding rapidly with Maxon Computer GmbH introducing Cinema 4D Release 21 (R21) for professional 3D modeling, animation, and rendering software solution

 

Animation design software has truly revolutionized the way that designers and artists communicate their creative ideas to the world. There are so many different types of software available, but most people end up settling on a particular type of program that either allows them to export their work to Flash, or to another program that does the same thing. While both of these programs are excellent at what they do, they are still quite different from one another and offer very different features. There are so many different things that a designer can do with his or her designs that it is important to understand the difference between the different software is.

Increasing use of animation design software in movies and the gaming industry is expected to drive growth of the global animation design software market. Animation software design has witnessed significant growth in various industries, especially in movies and gaming. Animation software plays a massive role in movies since it is used for numerous purposes. Similarly, in-game animation, animation software is used to create animations that respond to storytelling, gameplay, or mixing both together. For instance, in December 2018, Rive launched Flare, the animation design software, to allow designers to work directly with assets that run in their final app or game. Hence, such factors are expected to drive growth in the global animation design software market. Furthermore, increasing adoption of virtual reality (VR) animations for VR animation film-making is expected to propel the global animation design software market growth in the near future.

Availability of open-source animation design software is expected to restrain growth of the global animation design software market. Among regions, North America is expected to witness significant growth in the global animation design software market. This is owing to the presence of major market players such as Autodesk Inc., Adobe Systems, Pixar, and Side Effects Software Inc. Furthermore, Asia Pacific is expected to register a robust growth rate, owing to rapid growth of the gaming industry.

Major companies involved in the global animation design software market Autodesk Inc., Maxon Computer GmbH, Adobe Systems, Pixar, Toon Boom Animation Inc., Sony Picture Imageworks, Blender Foundations, and Side Effects Software Inc.

For instance, in July 2019, Maxon Computer GmbH launched next-generation animation design software Cinema 4D Release 21 (R21) for professional 3D modeling, animation, and rendering software solution.

Increasing Number of Surgical Procedures to Augment the Anesthesia Monitoring Devices Market Growth

 

Anesthesia is used to induce unconsciousness during a surgery. Anesthesia monitoring devices are used during a surgical process to check a patient's response toward anesthesia, as well as to track vital signs such as patient temperature, blood pressure, and heart rate under sedation in the operation theater. Moreover, these devices help reduce the risk involved in anesthesia. The need for these devices depends on the type of surgery and it varies in every case. Anesthesia monitoring devices help monitor the dose of anesthesia and reduces the risks involved in anesthesia and surgery.

Market Dynamics:

Increasing number of surgical procedures due to increasing incidence or prevalence of chronic diseases, such as cardiovascular diseases and cancer, is expected to propel the growth of the anesthesia monitoring devices market. According to the World Health Organization (WHO), cardiovascular diseases (CVDs) are the leading cause of death worldwide, taking an estimated 17.9 million lives each year.

Moreover, increasing incidence of spinal disorders and the growing geriatric population is expected to augment the growth of the anesthesia monitoring devices market. According to the National Spinal Cord Injury Statistical Center, each year, around 17,700 new cases of spinal cord injury are diagnosed in the United States. In 2018, around 54 people in the U.S. (per one million) suffered from spinal cord injury.

Furthermore, the introduction of various new monitoring techniques, such as goal-directed fluid therapy, monitoring the depth of anesthesia, advanced neurological monitoring, and technological advancements are expected to drive the market growth. However, increase in product recalls and high cost of anesthesia monitoring devices is expected to restrain the anesthesia monitoring devices market growth.

Competitive Analysis:

Key players operating in the anesthesia monitoring devices market are Masimo, Heyer Medical AG, Criticare Systems, Inc., Schiller AG, Drägerwerk AG & Co. KGAA, Philips Healthcare, GE Healthcare, Covidien PLC (a subsidiary of Medtronic Plc.), Infinium Medical, Fukuda Denshi, Nihon Kohden Corporation, and Mindray Medical International Limited.

In March 2021, Masimo announced the CE marking of the Rad-G with Temperature, a rugged handheld device that provides clinically proven SET pulse oximetry, respiration rate from the pleth (RRp), and other important parameters alongside clinical-grade, non-contact infrared thermometry.

In February 2021, Masimo announced the U.S. introduction of softFlow, innovative pulmonary care therapy which provides nasal high-flow warmed and humidified respiratory gases to spontaneously breathing patients.

In February 2021, Milestone Scientific Inc. announced that it has begun selling its CompuFlo Epidural Instrument and related disposables to the University Hospital of Wurzburg, one of the leading national hospitals in Germany.

Increasing Demand for Advanced Military Technologies and Increasing Investment in Military and Defense Sector to Augment Growth of Airborne Weapon Delivery Systems Market

 

There are three major types of airborne weapon delivery systems in development; Long-range Unmanned Aerial Vehicles (LAV), Short-range Unmanned Aerial Vehicle (SRAV), and Laser-guided Air Ballistic Missiles (AGM). There are several programs currently active for each category, including; Ground-based Air Defense, Air-dropped Firepower Capability (AFFC), and Robotic, and Unmanned Aerial Vehicle (URAV).

Market Dynamics

Increasing demand for advanced military technologies is expected to propel growth of the airborne weapon delivery systems market. For instance, in February 2021, BAE Systems secured a US$ 247 million contract from the U.S Space Force to deliver advanced military GPS receivers and chips for the troops.

Increasing investment in the military and defense sector is expected to offer lucrative growth opportunities for players in the airborne weapon delivery systems market. For instance, in March 2019, China's Ministry of Finance announced a yearly budget of US$ 177.5 billion for the defense sector compared to US$ 167.4 billion in 2018. Moreover, increasing in software defined radio systems is also expected to aid in growth of the market. For instance, in February 2021, India's Ministry of Defense and Defense Public Sector Undertaking Bharat Electronics Limited signed a contract for procurement of Software Defined Radio Tactical.

Among regions, North America is expected to witness significant growth in the airborne weapon delivery systems market, owing to increasing investment in airborne platforms. For instance, in November 2020, BAE Systems was awarded a five-year US$ 94 million single-award indefinite delivery indefinite quantity contract to deliver advanced technology capability to the U.S. Navy.

Competitive Analysis

Major players operating in the airborne weapon delivery systems market are focused on gaining contracts to enhance their market share. For instance, in February 2021, Cubic Corporation’s Cubic Mission and Performance Solutions business division received a contract to deliver P5 Combat Training System pods and auxiliary training hardware in support of the Combat Air Force Contracted Air Support program.

Major players operating in the airborne weapon delivery systems market are also focused on adopting various marketing strategies to enhance their market share. For instance, in February 2021, BAE Systems exhibited its product portfolio at Aero India’.

Major players operating in the airborne weapon delivery systems market include, Boeing, BAE Systems, General Dynamics, Elbit Systems, Cubic Corporation, CMC Electronics, Lockheed Martin, Raytheon, Northrop Grumman, and Saab.

In-depth Report on Airborne Weapon Delivery Systems Market by Coherent Market Insights:

https://www.coherentmarketinsights.com/ongoing-insight/airborne-weapon-delivery-systems-market-609